Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 3Other hematologic neoplasm 2Plasma cell 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 561Leukemia 282Precursor Cell Lymphoblastic Leukemia-Lymphoma 235Myelodysplastic Syndromes 110Congenital Abnormalities 86Leukemia, Monocytic, Acute 84Leukemia, Myelomonocytic, Acute 82Leukemia, Erythroblastic, Acute 75Leukemia, Megakaryoblastic, Acute 72Lymphoma 65Burkitt Lymphoma 62Recurrence 61Leukemia, Myelomonocytic, Chronic 43Leukemia, Biphenotypic, Acute 43Lymphoma, Non-Hodgkin 41Blast Crisis 37Anemia, Refractory, with Excess of Blasts 36Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Leukemia, Lymphocytic, Chronic, B-Cell 33Lymphoma, Large B-Cell, Diffuse 30Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 28Myeloproliferative Disorders 27Lymphoma, Follicular 27Lymphoma, Large-Cell, Immunoblastic 25Lymphoma, Mantle-Cell 24Leukemia, Myeloid, Chronic-Phase 23Leukemia, Eosinophilic, Acute 23Hodgkin Disease 23Lymphoma, B-Cell, Marginal Zone 22Leukemia, Basophilic, Acute 22

Interventions

fludarabine phosphate 6Cyclophosphamide 6fludarabine 4Whole-Body Irradiation 4Mycophenolic Acid 4tagraxofusp 3Thiotepa 3Methotrexate 3Cyclosporine 3venetoclax 2Tacrolimus 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2Dexamethasone 2Cytarabine 2Cyclosporins 2Calcium Dobesilate 2Azacitidine 2merphos 1lorvotuzumab mertansine 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1X-Rays 1Vincristine 1Sirolimus 1Salvia hispanica seed extract 1Rituximab 1Ranitidine 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Blastic Plasmacytoid Dendritic Cell Neoplasm × Cytarabine × Other hematologic neoplasm × Clear all
NCT06325748 2026-02-12

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

Senti Biosciences

Phase 1 Active not recruiting
21 enrolled
MyeloidOther hematologic neoplasmPlasma cell

Blastic Plasmacytoid Dendritic Cell Neoplasm, Multiple Myeloma, Recurrence, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT05476770 2024-12-06

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Recruiting
54 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hodgkin Disease, Leukemia, Biphenotypic, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡